Graded: “Making Music May Rewire the Addicted Brain”

Verdict: overstated. The study is a genuine first of its kind and it found something. It did not find what the headline says, and one of the brainwave results reported as a finding was not statistically significant in the paper.

The claim

Neuroscience News ran the study on 1 October 2026 under “Making Music May Rewire the Addicted Brain”, with a standfirst saying the pilot “reveals that music therapy directly modulates brain wave dynamics linked to emotional regulation and craving suppression”. Its key facts included: “EEG neuroimaging showed that music therapy dampened frontal beta wave oscillations, an electrophysiological signature elevated during active substance craving”, and in the body: “Patients receiving music therapy displayed marked reductions in frontal beta activity relative to control subjects.”

The story was picked up widely, including by talker.news (“Study finds music therapy may help ease drug and alcohol cravings”), the Cambridge Independent and Mirage News.

What the paper found

The paper is Pasqualitto and colleagues, “Music therapy in community-based substance misuse treatment: Exploring psychometric, qualitative and EEG measures related to craving, inhibition and affective processing”, in Addiction Neuroscience, published 11 September 2026 (doi:10.1016/j.addicn.2026.100281, open access). The team is at Anglia Ruskin University’s Cambridge Institute for Music Therapy Research.

It is a mixed-methods pilot with sixteen people from a community substance-use treatment service. Some received six weekly music therapy sessions on top of standard treatment; the others received standard treatment alone. The researchers collected resting-state and event-related EEG, questionnaires, and interviews. The authors describe it as the first study to combine these measures during music therapy for substance use disorder, and that claim looks right.

Taking the results in the paper’s own words:

• Within-session craving fell. Craving Thermometer ratings “suggested immediate reductions in present-moment craving after MT sessions”, and the authors note the improvement “may emerge primarily in the immediate post-session window”.
• The standardised craving measure showed nothing. Baseline-adjusted analyses found “no significant group differences at post intervention in Brief Substance Craving Scale scores”.
• Beta power showed nothing significant. The same sentence reports no significant group difference in “resting-state beta power z-scores, although the latter showed a larger descriptive reduction in the MT group”.
• Frontal alpha asymmetry did differ. Music therapy and standard treatment “differed significantly in post-intervention frontal alpha asymmetry after baseline adjustment”, which the authors offer as “a candidate domain for future research”.
• The inhibition measure showed nothing significant. The music therapy group showed “a nominal, non-significant increase in P3d amplitude” on a Go/NoGo task.

The authors’ own conclusion is that the pilot supports combining these measures in future work, and that “future trials with larger samples, robust allocation, clearer comparators and longer-term follow-up are needed”.

Why this is overstated

The beta claim is the concrete error. The paper says beta power did not differ significantly between groups and describes the difference as descriptive; the coverage says patients showed “marked reductions in frontal beta activity relative to control subjects” and lists the beta result among its key facts. A difference that does not reach significance in a 16-person study is not a marked reduction, and reporting it as one converts a trend the authors flagged as preliminary into a result.

The framing compounds it. “Rewire” is not a word this study earns: nothing here measures structural or lasting change, and the EEG was recorded over six weeks with no follow-up. “Reveals that music therapy directly modulates brain wave dynamics” asserts a causal mechanism from one significant difference on one measure in a pilot the authors explicitly built to test feasibility. The standardised craving scale, which is the outcome a clinician would want, was flat.

People felt less craving right after a music therapy session, which matters in a treatment setting even if it does not last. One EEG measure of emotional processing shifted. The qualitative interviews found craving reduction, emotional reflection and therapeutic connection as themes, along with a reluctance to discuss craving at all, which is a useful finding about the setting. That is a reasonable basis for a bigger trial and a poor basis for a headline about rewiring.

The syndicated versions came out better than the original. talker.news said “may help ease” and named the sample size and the measure, which is about right. Our verdict applies to the Neuroscience News framing, which is where the beta error and the rewiring language live.

Our grade on the study itself: the paper is not yet in our library. On the rubric it would land low, driven by sixteen participants, allocation the authors themselves call for making more robust, no blinding, and no replication. That is normal for a pilot and is not a mark against the researchers, who were careful in print. It is a reason to wait for the trial they are asking for.